STOCK TITAN

Standex International Corporation Form 4 Filings

SXI NYSE

Every Form 4 that Standex International Corporation (SXI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SXI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SXI filings page.

Rhea-AI Summary

Standex International (SXI): A company director reported a grant of 639 restricted shares of common stock on 10/21/2025 at $0 under the company’s 2018 Omnibus Incentive Plan. The award is scheduled to vest three years after the grant date.

Following this transaction, the director’s beneficial ownership stands at 12,905.4464 shares, held directly. This filing records an equity compensation award and does not indicate any open‑market purchase or sale.

Rhea-AI Summary

Standex International (SXI) reported an insider equity award. Director Alan J. Glass acquired 639 shares of common stock on 10/21/2025 via a restricted stock grant under the Company’s 2018 Omnibus Incentive Plan. The award carries a $0 price, reflecting a grant rather than an open‑market purchase, and vests three years after the date of grant.

Following this transaction, the reporting person beneficially owned 14,424 shares, held directly.

Rhea-AI Summary

Standex International (SXI) reported an insider equity award. A company director acquired 639 shares of Common Stock on 10/21/2025 at $0 via a restricted stock grant under the 2018 Incentive Plan.

The award vests three years after the date of grant. After this transaction, the director beneficially owns 4,698.089 shares, held directly.

Rhea-AI Summary

Standex International (SXI) disclosed a Form 4 indicating a director received 639 shares of common stock on 10/21/2025 as a restricted stock grant under the company’s 2018 Omnibus Incentive Plan.

The award was recorded at $0 per share and vests three years after the grant date. Following this transaction, the reporting person beneficially owns 6,285 shares, held directly.

Rhea-AI Summary

Standex International (SXI) reported an insider equity award. A director received a grant of 639 shares of common stock on 10/21/2025, coded as an acquisition under the company’s 2018 Omnibus Incentive Plan. The grant price was $0, and the restricted stock is scheduled to vest three years after the grant date.

Following this grant, the reporting person beneficially owns 6,639 shares, held directly. This filing reflects routine director compensation in equity rather than an open‑market purchase or sale.

Rhea-AI Summary

Standex International (SXI) director reported an equity grant. On 10/21/2025, the reporting person acquired 639 shares of common stock as a grant of restricted stock under the Company’s 2018 Omnibus Incentive Plan, vesting three years after the grant date. The filing lists the transaction price as $0, consistent with a stock grant. Following the grant, the filer beneficially owned 3,575 shares directly and 13,751 shares indirectly as trustee of a trust.

Rhea-AI Summary

Standex International (SXI) reported a director’s Form 4 showing stock acquired through the vesting of phantom stock units tied to the director’s retirement. On 10/21/2025, the director acquired common stock via transaction code M in three lots: 663 shares at $106.10, 581 shares at $120.86, and 599 shares at $117.36. Following these transactions, the director beneficially owned 11,389.254 shares directly. The related phantom stock unit awards were converted, leaving 0 derivative securities beneficially owned after the reported transactions.